Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. XRAY

Market Cap: $2.1B

DI

DENTSPLY SIRONA Inc.

XRAY
NASDAQUSD
Purchase XRAY
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin49.52%
EBITDA Margin4.72%
EBIT Margin-7.03%
Pre-tax Margin-9.53%
Net Profit Margin-14.99%
Earnings Yield-26.14%
Valuation Multiples
Price / Book1.55
Price / Sales0.58
Price / Earnings-3.82
PEG-0.07
Forward PEG6.11
EV / Sales1.14
EV / EBITDA24.23
EV / Operating Cash Flow13.07
EV / Free Cash Flow29.15
Price / Free Cash Flow14.65
Price / Operating Cash Flow6.55
Cash Flow & Capital
Free Cash Flow / Share$0.72
Operating Cash Flow / Share$1.6
Free Cash Flow Yield6.82%
Capex / Revenue4.83%
Capex / Operating Cash Flow55.17%
Capex / Depreciation0.50
Stock Compensation / Revenue0.85%
Dividend Payout Ratio-17.58%
Dividend Yield3.06%
Liquidity & Leverage
Current Ratio1.63
Quick Ratio1.07
Cash Ratio0.20
Debt / Assets0.44
Debt / Capital0.63
Debt / Equity1.71
Long-Term Debt / Capital0.60
Debt / Market Cap1.06%
Net Debt / EBITDA12.05
Solvency Ratio-0.03
Financial Leverage3.85
Efficiency & Working Capital
Asset Turnover0.70
Fixed Asset Turnover3.74
Inventory Turnover2.77
Receivables Turnover5.88
Payables Turnover7.07
Days Sales Outstanding62.12
Days Inventory Outstanding131.99
Days Payables Outstanding51.6
Operating Cycle194.11
Cash Conversion Cycle142.5
Working Capital Turnover5.28
Returns & Quality
Return on Equity-39.81%
Return on Assets-10.49%
Return on Invested Capital10.03%
ROCE10.60%
Return on Tangible Assets-17.08%
Operating Return on Assets8.17%
Income Quality-0.58
Tax Burden1.57
Interest Burden1.36
Balance Sheet & Intrinsic Metrics
Enterprise Value$4.17B
Invested Capital$3.73B
Working Capital$743M
Tangible Asset Value$-657M
Net Current Asset Value$-1.93B
Graham Net-Net-$14.1
Book Value / Share$6.77
Tangible Book Value / Share-$3.29
Cash / Share$1.2
Financial Health Scores
Piotroski Score5
Altman Z-Score0.62
Revenue$3.64B
EBIT$-256M
Market Cap$2.1B
Working Capital$743M
Retained Earnings$-1.54B
Total Assets$5.2B
Total Liabilities$3.85B